Finoriq research workspace
THERMO FISHER SCIENTIFIC INC. (TMO) SEC Filings & Filing Highlights
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty. Review TMO SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
- Company
- THERMO FISHER SCIENTIFIC INC. (TMO)
- Ticker
- TMO
- Market Cap
- $195.9B
- Latest Price
- $527.09
- Industry
- Industrial Machinery
THERMO FISHER SCIENTIFIC INC. (TMO) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for THERMO FISHER SCIENTIFIC INC. (TMO).
| Event | Form | Date |
|---|---|---|
| At the Annual Meeting held on May 20, 2026, the shareholders of the Company voted on the follow...At the Annual Meeting held on May 20, 2026, the shareholders of the Company voted on the following proposals | 8-K5.07 | 2026-05-26 |
| Thermo Fisher ScientificThermo Fisher Scientific Reports First Quarter 2026 Results | 8-K2.02 | 2026-04-23 |
| THERMO FISHER SCIENTIFIC INC.: Corporate updateOn March 24, 2026, Thermo Fisher Scientific Inc. (“Thermo Fisher”) issued a press release announcing the completion of its acquisition of C... | 8-K8.01 | 2026-03-24 |
| THERMO FISHER SCIENTIFIC INC.: Corporate updateThe sale of the Notes was made pursuant to the terms of an Underwriting Agreement, which the Company entered into on February 9, 2026 (the... | 8-K8.01 | 2026-02-12 |
| THERMO FISHER SCIENTIFIC INC.: Material agreementOn February 12, 2026, Thermo Fisher Scientific Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 4.215% Senior Notes... | 8-K1.01 | 2026-02-12 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.